Alan R Kimmel

Title: Alan R Kimmel: Innovator in Perilipin Protein Research

Introduction

Alan R Kimmel is a notable inventor based in Ashton, MD (US). He has made significant contributions to the field of molecular biology, particularly in the study of perilipin proteins. With a total of 2 patents, Kimmel's work has implications for understanding adipocyte biology and related pathophysiological conditions.

Latest Patents

Kimmel's latest patents focus on the cloning of perilipin proteins. The inventions provide isolated nucleic acid sequences, specifically polynucleotides, that encode a family of perilipin proteins. These isolated and substantially purified perilipin proteins serve as markers for differentiating true adipocytes from non-adipocyte cells that, due to various conditions, take on adipocyte characteristics and become lipid-laden. Additionally, the patents outline methods for producing substantially purified perilipin proteins and detecting their presence in biological samples.

Career Highlights

Throughout his career, Kimmel has worked with esteemed organizations, including the United States of America and the United States of America as represented by the Department of Health. His research has contributed to advancements in understanding the role of perilipin proteins in cellular biology.

Collaborations

Kimmel has collaborated with notable colleagues such as Constantine Londos and Andrew S Greenberg. These partnerships have further enriched his research and innovations in the field.

Conclusion

Alan R Kimmel's work in cloning perilipin proteins has opened new avenues for research in adipocyte biology. His contributions are vital for advancing our understanding of lipid metabolism and related health conditions.